Lisinopril Tablets USP — Class II drug recall D-1079-2020
Terminated recall by Lupin Pharmaceuticals Inc., reported 2020-04-08, distributed nationwide. Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet
| Recall number | D-1079-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lupin Pharmaceuticals Inc., Baltimore, MD, United States |
| Recall initiated | 2020-04-01 |
| Classified | 2020-04-02 |
| Reported by FDA | 2020-04-08 |
| Terminated | 2021-06-30 |
| Distributed | Nationwide (US) |
| Quantity | 25,944 bottles |
| NDC | 68180-0512, 68180-0512-01, 68180-0512-02, 68180-0512-03, 68180-0512-09, 68180-0512-30, 68180-0513, 68180-0513-01, 68180-0513-02, 68180-0513-03, 68180-0513-05, 68180-0513-09, 68180-0513-30, 68180-0514, 68180-0514-01, 68180-0514-02, 68180-0514-03, 68180-0514-05, 68180-0514-09, 68180-0514-30, 68180-0515, 68180-0515-01, 68180-0515-02, 68180-0515-03, 68180-0515-05 and 40 more |
| Lot numbers | Q900580 |
| Expiration dates | 2021-09 |
Product
Lisinopril Tablets USP, 30 mg, 100-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-982-01
Reason for recall
Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1079-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.